It returns which of two targets binds a compound more tightly. It has no opinion on whether the compound binds either one at all, so a confident ranking of two targets it barely touches is still a confident ranking.
The same forest with the ligand removed scores 0.710, against 0.750 with it. The compound contributes about four points. That is a real and reproducible contribution, and it is far less than the headline suggests on its own. Read the headline against the baselines, never alone.
Where the two measured values sit within half a log the model is right 0.573 of the time, which is close to a coin flip. It reaches 0.915 only when the true separation is beyond two logs. The strength returned with a comparison is the guide to which case you are in.
Across pairings carrying at least 100 held-out comparisons:
| Pairing | Comparisons | Accuracy |
|---|---|---|
| Kinase against Voltage-gated ion channel | 144 | 0.931 |
| Cytochrome P450 against Kinase | 278 | 0.899 |
| Cytochrome P450 against Oxidoreductase | 105 | 0.886 |
| Family A G protein-coupled receptor against Voltage-gated ion channel | 180 | 0.878 |
| and the hardest | ||
| Electrochemical transporter against Family A G protein-coupled receptor | 531 | 0.655 |
| Cytochrome P450 against Voltage-gated ion channel | 121 | 0.744 |
| Eraser against Kinase | 121 | 0.744 |
| Kinase against Transferase | 775 | 0.748 |
Pairings with fewer than 30 held-out comparisons are not quoted at all, here or in the manifest.
The strength returned with a comparison is not the probability that the particular answer is right. It is a ranking signal whose reliability was measured across a large held-out set. A comparison at or above 0.80 belongs to a population that is right 0.933 of the time.
1,879 targets across 38 families are servable, and a target outside that roster is refused rather than guessed at. Targets are named by UniProt accession because gene symbols are many-to-many against accessions and the failure is silent.
A compound that ranks highly against many families is not thereby promiscuous or unsafe. Cross-family breadth in this data partly records how many assay panels a compound went through. This is an off-target triage and repurposing tool, and that is the claim the measurements support.
Built as of 13 September 2026.